Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer [NA]

View source ↗

Summary

This clinical trial update notes ongoing recruitment for a study evaluating urinary tumor DNA testing to guide cystoscopy in high-risk/non-muscle-invasive bladd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Bladder Cancer, Liquid Biopsy | NA | Status: RECRUITING